Abstract
Esophageal cancer (EC) is an aggressive tumor that represents the 6th most common cause of cancer death worldwide. The estimated incidence in Spain is 2090 cases/year. Two main pathological subtypes exist, squamous cell carcinoma and adenocarcinoma. The main differences between them are localization and underlying factors which are the principal cause of the recent incidence changes observed in west countries. Staging techniques and treatment options which combine surgery, chemotherapy and radiotherapy, reflected the high complexity of the EC management. An undeniably multidisciplinary approach is, therefore, required. In this guide, we review the status of current diagnosis and treatment, define evidence and propose recommendations.
Highlights
CLINICAL GUIDES IN ONCOLOGYSEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016). M
We review the status of current diagnosis and treatment, define evidence and propose recommendations
While Tobacco, alcohol, mate, nitrogenous compounds, chewing betel nut and deficits of minerals and vitamins have been associated with squamous cell carcinoma (SCC), tobacco, gastroesophageal reflux, Barrett’s esophagus, obesity and lowfiber diet have been linked with ADC [2]
Summary
SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016). M. This article is published with open access at Springerlink.com
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.